NOVUS THERAPEUTICS INC's ticker is NVUS and the CUSIP is 67011N105. A total of 18 filers reported holding NOVUS THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,000 | -25.0% | 2,546 | +160.3% | 0.00% | – |
| Q1 2019 | $4,000 | +100.0% | 978 | -20.0% | 0.00% | – |
| Q4 2018 | $2,000 | -60.0% | 1,223 | +12.4% | 0.00% | – |
| Q3 2018 | $5,000 | -99.9% | 1,088 | +103.7% | 0.00% | – |
| Q2 2018 | $3,738,000 | +93350.0% | 534 | -29.3% | 0.00% | – |
| Q1 2018 | $4,000 | 0.0% | 755 | -30.4% | 0.00% | – |
| Q4 2017 | $4,000 | -20.0% | 1,084 | +19.5% | 0.00% | -100.0% |
| Q3 2017 | $5,000 | 0.0% | 907 | 0.0% | 0.00% | – |
| Q2 2017 | $5,000 | – | 907 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 80,069 | $1,233,000 | 0.56% |